Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffry P Simko

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Urology|December 29, 2025
Whole-Slide Telepathology Grading of Prostate Cancer in Biopsies Using ISUP Criteria: Inter- and Intra-Observer Concordance and Implications for Active SurveillanceM Scott Lucia, Sam Callis, Catherine Tangen, et al.
Histopathology|August 5, 2025
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsiesChien-Kuang C Ding, Huijun Xiao, Jane K Nguyen, et al.
NMR in Biomedicine|December 25, 2009
Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopyCarissa F Santos, John Kurhanewicz, Z Laura Tabatabai, et al.
European Urology Focus|May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional CohortKevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
Cancer|January 27, 2024
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancerAvery E Braun, June M Chan, John Neuhaus, et al.
BMC Cancer|August 30, 2020
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancerClinton L Cario, Emmalyn Chen, Lancelote Leong, et al.
Magnetic Resonance in Medicine|August 30, 2008
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissuesMay-Britt Tessem, Mark G Swanson, Kayvan R Keshari, et al.
European Urology Oncology|July 29, 2023
First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted ProstatectomyHao G Nguyen, Nynke S van den Berg, Alexander L Antaris, et al.
Cancer|October 21, 2017
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, et al.
European Urology|November 5, 2020
Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology OutcomesMatthew R Cooperberg, Janet E Cowan, Karla J Lindquist, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Urology|December 29, 2025
Whole-Slide Telepathology Grading of Prostate Cancer in Biopsies Using ISUP Criteria: Inter- and Intra-Observer Concordance and Implications for Active SurveillanceM Scott Lucia, Sam Callis, Catherine Tangen, et al.
Histopathology|August 5, 2025
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsiesChien-Kuang C Ding, Huijun Xiao, Jane K Nguyen, et al.
NMR in Biomedicine|December 25, 2009
Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopyCarissa F Santos, John Kurhanewicz, Z Laura Tabatabai, et al.
European Urology Focus|May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional CohortKevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
Cancer|January 27, 2024
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancerAvery E Braun, June M Chan, John Neuhaus, et al.
BMC Cancer|August 30, 2020
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancerClinton L Cario, Emmalyn Chen, Lancelote Leong, et al.
Magnetic Resonance in Medicine|August 30, 2008
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissuesMay-Britt Tessem, Mark G Swanson, Kayvan R Keshari, et al.
European Urology Oncology|July 29, 2023
First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted ProstatectomyHao G Nguyen, Nynke S van den Berg, Alexander L Antaris, et al.
Cancer|October 21, 2017
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, et al.
European Urology|November 5, 2020
Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology OutcomesMatthew R Cooperberg, Janet E Cowan, Karla J Lindquist, et al.
Pageof 10